S 957referred119th Congress

Honor Our Living Donors Act

Introduced Mar 11, 2025Senate billPolicy area: HealthLast action Mar 11, 2025Sponsor: Ben Ray Luján(D-NM)

healthcareHealth

Health, Education, Labor, and Pensions Committee

Ask about this Build timeline Compare Export source pack

Official Congress record Open in Network Lab Trace connections

Lobbying Filings

$53.5M

Total Lobbying Spend

Suspicious Trades

Members Involved

Timeline

Jan 24, 2025trade

Gilbert Ray Cisneros, Jr. bought K

Mar 11, 2025bill

Bill introduced

Apr 8, 2025trade

Robert P. Bresnahan, Jr. bought K

Apr 15, 2025lobbying

Lobbying filed by AMERICAN SOCIETY OF NEPHROLOGY

Apr 21, 2025lobbying

Lobbying filed by NATIONAL KIDNEY FOUNDATION

Apr 29, 2025trade

Gilbert Ray Cisneros, Jr. bought K

Official Congressional Actions

Mar 11, 2025IntroReferral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions Committee

View official action

Mar 11, 2025IntroReferral

Introduced in Senate

View official action

Lobbying Activity

Registrant	Client	Amount	Filed	Period	Issues
NATIONAL KIDNEY FOUNDATION	NATIONAL KIDNEY FOUNDATION	$11.0M	Apr 21, 2025	2025Q1	BUDHCRMMM
NATIONAL KIDNEY FOUNDATION	NATIONAL KIDNEY FOUNDATION	$9.0M	Jul 20, 2025	2025Q2	BUDHCRMMM
AMERICAN SOCIETY OF NEPHROLOGY

Suspicious Trading Activity

Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.

Member	Party	Ticker	Company	Trade	Date	Amount	Timing	Lobbying Client	Conflict
Robert P. Bresnahan, Jr.	R	K	K	Buy	Apr 8, 2025	$1,001 - $15,000	28d after	NATIONAL KIDNEY FOUNDATION	37%
Gilbert Ray Cisneros, Jr.	D

Conflict Summary

3 trades by 2 members of Congress in companies connected to lobbying on S 957. The average conflict score is 35%.

Robert P. Bresnahan, Jr. (1 trade)Gilbert Ray Cisneros, Jr. (2 trades)

Methodology: Bill-Lobbying-Trade Connection

CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.